Search research articles
Contact Us
Filters
Showing results (71-80 of 122) with videos related to
Page
of 13
Sort By:
Current Oncology (Toronto, Ont.)
|
May 5, 2021
Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer
Satomi Hattori, Nobuhisa Yoshikawa, Kazumasa Mogi, et al.
Plos One
|
November 25, 2024
Histology-specific long-term oncologic outcomes in patients with epithelial ovarian cancer who underwent complete tumor resection: The implication of occult seeds after initial surgery
Kazumasa Mogi, Masato Yoshihara, Ryo Emoto, et al.
Cancer Medicine
|
April 4, 2024
Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer
Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, et al.
BMC Cancer
|
January 4, 2022
Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study
Masato Yoshihara, Kaoru Kitamura, Satoko Tsuru, et al.
Molecular Genetics and Metabolism Reports
|
October 24, 2022
A case of non-immune hydrops fetalis with maternal mirror syndrome diagnosed by trio-based exome sequencing: An autopsy case report and literature review
Sho Tano, Tomomi Kotani, Masato Yoshihara, et al.
Oncology Reports
|
December 2, 2017
A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer
Kayo Fujikake, Hiroaki Kajiyama, Masato Yoshihara, et al.
Cancer Medicine
|
August 8, 2025
Development and Validation of Predictive Risk Scores for Ovarian Clear Cell Carcinoma: A Penalized Regression Model
Shohei Iyoshi, Ryo Emoto, Nobuhisa Yoshikawa, et al.
Cancer Letters
|
November 16, 2018
PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
Yang Peng, Hiroaki Kajiyama, Hong Yuan, et al.
International Journal of Molecular Sciences
|
February 10, 2024
Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer
Kaname Uno, Yoshihiro Koya, Masato Yoshihara, et al.
International Journal of Clinical Oncology
|
October 7, 2023
Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma
Nobuhisa Yoshikawa, Tetsuya Matsukawa, Satomi Hattori, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 122) with videos related to
Sort By:
Page
of 13
Current Oncology (Toronto, Ont.)
|
May 5, 2021
Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer
Satomi Hattori, Nobuhisa Yoshikawa, Kazumasa Mogi, et al.
Plos One
|
November 25, 2024
Histology-specific long-term oncologic outcomes in patients with epithelial ovarian cancer who underwent complete tumor resection: The implication of occult seeds after initial surgery
Kazumasa Mogi, Masato Yoshihara, Ryo Emoto, et al.
Cancer Medicine
|
April 4, 2024
Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer
Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, et al.
BMC Cancer
|
January 4, 2022
Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study
Masato Yoshihara, Kaoru Kitamura, Satoko Tsuru, et al.
Molecular Genetics and Metabolism Reports
|
October 24, 2022
A case of non-immune hydrops fetalis with maternal mirror syndrome diagnosed by trio-based exome sequencing: An autopsy case report and literature review
Sho Tano, Tomomi Kotani, Masato Yoshihara, et al.
Oncology Reports
|
December 2, 2017
A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer
Kayo Fujikake, Hiroaki Kajiyama, Masato Yoshihara, et al.
Cancer Medicine
|
August 8, 2025
Development and Validation of Predictive Risk Scores for Ovarian Clear Cell Carcinoma: A Penalized Regression Model
Shohei Iyoshi, Ryo Emoto, Nobuhisa Yoshikawa, et al.
Cancer Letters
|
November 16, 2018
PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination
Yang Peng, Hiroaki Kajiyama, Hong Yuan, et al.
International Journal of Molecular Sciences
|
February 10, 2024
Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer
Kaname Uno, Yoshihiro Koya, Masato Yoshihara, et al.
International Journal of Clinical Oncology
|
October 7, 2023
Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma
Nobuhisa Yoshikawa, Tetsuya Matsukawa, Satomi Hattori, et al.
Page
of 13